series-c-plus
Stage
3
Investors
About
Genenta Science is a clinical-stage biotechnology company developing a gene transfer platform based on hematopoietic stem cells. Their technology aims to treat cancer by delivering therapeutic proteins directly to tumors.
Explore Genenta Science's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.